IC2PerMed key activity consist in developing appropriate approaches for Chinese and EU cooperation over Personalised Medicine research and innovation under the umbrella set by ICPerMed initiative.
3 Working groups (WG), constituted of experts balanced between EU and Chinese stakeholders and genders, support IC2PerMed consortium on following activities :
Working Group 1 – Shaping sustainable healthcare
- Awareness and empowerment
- Education and curricula
- Personalised Medicine in sustainable healthcare
Working Group 2 – Innovation and market
- Big data and ICT solutions
- Bringing innovation to market
Working Group 3 – Research and clinical studies in Personalised Medicine
- Translating basic clinical research and beyond
- Research Funding
- Set a consistent conceptual framework for PM-related developments, by analysing potentials and challenges for EU-China collaboration in the fields and the needs for policy, programmes and actions to improve such conditions for upcoming collaborations
- Identify research and innovation collaboration opportunities and potential projects supporting the setup of a sustainable, equitable PM developments
- Contribute to the barriers and opportunities reports, to develop common views on the priorities and EU-China collaboration will provide improved competitiveness, performance and reinforced rights to patients
- Propose new schemes for developing and co-developing strategic initiatives and actions that will foster the uptake of ICPerMed Actions by Chinese funding agencies
- Help in linking EU and Chinese networks for mobilising the relevant stakeholders upon given topics
For more information or joining expert groups activities, please contact us